Search results
JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch
Johnson & Johnson's JNJ MedTech division, which spans orthopedics, surgery, cardiovascular and vision care, contributes roughly 36% to the company’s total revenues.
J&J is repositioning its MedTech


